Rapidly evolving safety risk management processes increasingly dictate drug approval and post-marketing surveillance. To meet FDA requirements of developing and implementing changes to risk-evaluation and mitigation strategies (REMS), and to streamline this complicated process, we have detailed a framework of key concepts, standards and submissions procedures.